SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to Alexion Pharmaceuticals, Inc. -- GEVA

May 18, 2015, 16:10 ET from Levi & Korsinsky, LLP

NEW YORK, May 18, 2015 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Synageva BioPharma Corp. stock prior to May 6, 2015.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Synageva BioPharma Corp. (NASDAQ: GEVA) to Alexion Pharmaceuticals, Inc. for $115 in cash and 0.6581 Alexion shares per Synageva share. To learn more about the investigation and your rights, go to:

or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171

Logo -

SOURCE Levi & Korsinsky, LLP